Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. Shareholder Equity 2022–2025
Indivior Pharmaceuticals, Inc. annual shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Indivior Pharmaceuticals, Inc. shareholder equity as of December 31, 2025: -98.0M, a 70.92% decrease year-over-year.
- Indivior Pharmaceuticals, Inc. shareholder equity for 2025 were -98.0M, a 70.92% decrease from 2024.
- Indivior Pharmaceuticals, Inc. shareholder equity for 2024 were -337.0M, a 83.15% increase from 2023.
- Indivior Pharmaceuticals, Inc. shareholder equity for 2023 were -184.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Indivior Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-98 |
| 2024 | $-337 |
| 2023 | $-184 |
Indivior Pharmaceuticals, Inc. Shareholder Equity — FAQ
Indivior Pharmaceuticals, Inc. (INDV) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INDV's shareholder equity history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.